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Scavenger receptor expressed by endothelial cell-I (SREC-I) is a class F scavenger 
receptor expressed by immune cells with a significant role in CD8+- and CD4+-mediated 
T cell immunity. This receptor can also modulate the function of toll-like receptors (TLRs), 
which play essential roles in innate immunity. Earlier, it was found that human monocyte/
macrophage THP1 cells and bone marrow-derived macrophages from mice exhibited 
increased responses to polyinosine–polycytidylic acid (poly I:C, PIC) and CpG (unmet-
hylated) DNA and enhanced production of inflammatory cytokines with overexpressed 
SREC-I. Our data also showed that intracellular/endocytic TLR3 and TLR9 could directly 
interact with SREC-I in the presence of their respective ligands. We also observed that the 
internalized ligand along with TLR3/TLR9 colocalized in the endosome in macrophages 
and THP-1 cells overexpressing these receptors. In the absence of these ligands, there 
was no detectable colocalization between the SREC-I and endocytic TLRs. Earlier, it was 
shown that SREC-I stimulated double-stranded RNA/CpGDNA-mediated TLR3/TLR9 
activation of the innate immune response by triggering signaling through the NF-κB, 
IRF3, and MAP kinase pathways leading to transcription of cytokine genes. We also 
established that SREC-I can associate with plasma membrane TLRs, such as TLR2 and 
TLR4. We demonstrated that SREC-I–TLR4 signals more efficiently from lipid micro-
domain in which lipopolysaccharide (LPS) can associate with SREC-I–TLR4 complex. 
We also proved that SREC-I is an alternate receptor for LPS capable of internalizing 
the complex and for endocytic TLR ligands as well. This binding activated endocytic 
TLR-mediated downstream cytokine production in THP1 cells and macrophages. Finally, 
SREC-I could also form complexes with TLR2 and induce the release of cytokines in the 
presence of bacterial, viral, and fungal ligands.
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iNTRODUCTiON
Scavenger receptors constitute a large family of protein molecules, which were identified by Brown 
and Goldstein in the year 1979 (1, 2). Their function was first characterized as the receptors 
capable of scavenging oxidized low-density lipoprotein (ox-LDL) (3). While initially identified 
to recognize modified self-molecules, SRs have since been shown to also recognize numerous 
pathogen-derived molecules and regulate the ensuing immune response. SRs are categorized into 
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10 class types designated A–J, although with very little sequence 
conservation between these groups. Nevertheless, this apparent 
lack of homology between SR classes is not reflected by the 
number of ligands recognized by multiple SR members as many 
of the structurally distinct SRs recognize common ligands (4–7). 
The ability of SRs to transmit ligand-specific biological signals 
combined with various ligands bound by some individual SR 
members is both remarkable and yet to be fully understood at 
the molecular level.
Here, we discuss how a member of scavenger receptor family 
F, scavenger receptor expressed by endothelial cell-I (SREC-I), 
cooperates with toll-like receptors (TLRs) and modulates its 
downstream signal activation in response to specific ligand 
stimulation. Also known as SCARF-I, SREC-I is an 86-kDa 
protein with an extended extracellular domain, which is com-
posed of epidermal growth factor (EGF)-like cysteine rich motifs, 
characteristic of the class F group of SRs (8–10). Known SREC-1 
ligands include modified LDL (including oxidized, acetylated, 
and carbamylated forms), lipopolysaccharide (LPS), apoptotic 
bodies, Hsp70, Hsp90, calreticulin, gp96, and zymogen granule 
protein 2 (GP2) (11). In the case of apoptotic bodies, heat shock 
protein (Hsp)70, Hsp90, calreticulin, gp96, and GP2, SREC-I 
recognition leads to engulfment and/or endocytosis. In the 
absence of known ligands, SREC-1 was shown to promote cell–
cell homophilic interactions between murine fibroblast cells, an 
effect that was amplified upon coculture with SREC-II-expressing 
cells and negated by the SREC-I ligands AcLDL and ox-LDL 
(9). These findings identified a potential ligand-independent 
role for SREC-I in cell–cell interactions, a function possessed 
by other SRs, such as LOX-1, which was shown to facilitate 
leukocyte–endothelium adhesion (12). SREC-I receptor has also 
been shown to induce morphological changes in neurons via its 
intracellular domain (4).
SREC-I was found to be a key receptor for HSPs and also to 
play a key role in immune response (13–15). It was demonstrated 
that HSP–tumor antigen complexes could be internalized after 
interacting with this receptor expressed in antigen-presenting 
cells such as dendritic cells. Antigens internalized in this way 
could later be processed and presented to T cells, thereby acti-
vating adaptive immunity. It was shown that HSP-chaperoned 
tumor antigen could be presented to both CD8+ and CD4+ T 
cells to activate immune response, which is also known as T 
cell priming (14, 15). However, further investigation is required 
to understand basic mechanisms and selectivity of SREC-I 
involved in T cell priming via MHCI and MHCII molecules. 
SREC-I, a potent antigen cross-presenting HSP receptor, is also 
known to induce inflammatory responses through interaction 
and cross-talk with another group of receptors  –  TLRs. One 
method by which microbes are detected by innate cells is through 
engagement of these pattern-recognition receptors (PRRs). TLRs 
recognize the presence of pathogen-associated molecular pattern 
(PAMP) molecules, leading to downstream signal transduction 
triggering and the activation of innate cells (16, 17). While some 
TLR members, such as TLR1, 2, 4, 5, and 6, can be detected on 
the plasma membrane and recognize components of microbial 
membranes, others, such as TLR3, 7, and 9, are intracellular 
proteins are characterized as “endosomal TLRs” and recognize 
nucleic acids (16, 18). In some cases, SREC-I can cooperate with 
TLRs in signal transduction, and this molecule was demonstrated 
to be important as a scavenger receptor in the control of infec-
tions (19–22). SREC-I has been shown to cooperate with multiple 
TLRs to transmit ligand-specific signals and to function as a 
potent antigen-presenting receptor for HSP-associated antigens. 
SReC-i COOPeRATeS wiTH TLR4 TO 
ACTivATe LPS-iNDUCeD iNFLAMMATiON
To date, TLR4 is the most studied TLR member. TLR4 initiates 
inflammatory responses upon binding to LPS of Gram-negative 
bacteria. In this context, transduction of the TLR4 activation 
signal is facilitated by adaptor molecules, such as CD14 and 
MD-2. CD14 is termed as a recognizing receptor for TLR4. 
Once activated, TLR4 recruits the TIR domain-containing 
adaptors (TIRAP) and MyD88 and activates transcription fac-
tors, such as NF-κB, IRF3, NF-IL6, and AP-1, that will lead 
to the production of pro-inflammatory cytokines (23). In some 
circumstances, SREC-I can recognize LPS in the absence of 
CD14 (24) (Figure  1). Upon LPS binding, SREC-I and TLR4 
activate NF-κB and MAP kinases and the subsequent production 
of inflammatory cytokines, such as IL-6, TNF-α, and IFN-β (25). 
Interestingly, IL-1α, IL-1β, and TNF-α were shown to inhibit 
SREC-I promoter activity, potentially representing a negative 
feedback loop to limit inflammatory signaling during contexts 
where levels of inflammatory cytokines are high (26). In the 
presence of LPS, SREC-I was shown to cause the translocation of 
TLR4 to lipid microdomains on cell surface (25) where signaling 
event initiates. Then, this complex (LPS–TLR4–SREC-I) appeared 
to become internalized to intracellular endosomes (25). In the 
presence of LPS, SREC-I and TLR4 translocated into lipid micro-
domains on plasma membrane and initiated pro-inflammatory 
signaling events from this location (Figure 1). We observed their 
presence in lipid microdomain when isolated using Optiprep 
density gradient centrifugation. One could hypothesize that the 
localization of SREC-I to lipid microdomains in the presence of 
some ligands promotes SREC-I interaction with certain TLRs by 
concentrating their proximity in these membrane substructures. 
Lipid microdomains are important signaling nexi for many 
surface molecules (27).
SReC-i AND iTS COLLABORATive 
FUNCTiON wiTH TLR2
TLR2 can recognize a broad range of bacterial-, parasitic-, viral-, 
and fungal-derived PAMPs (28). This receptor can form heter-
odimers with other cell surface TLRs, such as TLR1 and TLR6, 
depending on its ligand (28). TLR2 also cooperates with SREC-I 
in the recognition of certain pathogens. For example, SREC-I and 
the other c-type lectin, scavenger receptor LOX-1 induced the 
production of IL-6 and IL-8 in the presence of outer membrane 
protein A (OmpA) from Klebsiella pneumonia, a response depend-
ent on TLR2 (19). SREC-I also recognized β-glucans present on 
FiGURe 1 | SReC-i triggered immunity in cooperation with TLRs. (A) Molecules derived from pathogens are recognized by both SREC-I and TLR2, activating 
signaling, and triggering the release of cytokines. (B) The complex LPS/SREC-I/MD-2/TLR4/CD14 launches an inflammatory cascade mediated by the activation of 
MAP kinases, transcription factors, and the presence of inflammatory cytokines. (C) Hsp70–Ag interacts with SREC-I/TLR complexes present on antigen-presenting 
cells and then becomes internalized. Acquired antigens are processed and presented to MHC class I and class II molecules activating CD8+ and CD4+ T cells, 
respectively. (D) SREC-I can recognize viral dsRNA such as PIC. SREC-I engagement leads to the recruitment of the complex SREC-I/TLR3/PIC to endosomes with 
low pH. TLR3 is then able to trigger the activation of MAP kinases, transcription factors, and the production of inflammatory cytokines.
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the cell surface of fungi species Cryptococcus neoformans and 
Candida albicans and triggered the production of IL-1β and the 
chemokines, CXCL2 and CXCL1 in association with TLR2 (20). 
After hepatitis C virus stimulation, dendritic cells could recog-
nize and lead to endocytosis of the non-structural protein 3 (NS3) 
through SREC-I and produce IL-6 in a TLR2-dependent manner 
(21), although there was no evidence of their direct interaction 
or binding.
eNDOCYTiC TLR3 ReQUiReS SReC-i 
FOR LiGAND ReCOGNiTiON AND 
iNTeRNALiZATiON iN SOMe 
MONOCYTiC CeLLS
During viral infections, viral double-stranded RNA (dsRNA) 
can be recognized by immune cell as a PAMP, indicating viral 
infection (29, 30). TLR3 is an intracellular member of the TLR 
family, present in the endosomes, and it has a unique capacity of 
recognizing and activation by viral dsRNA (31, 32). Once engaged 
by viral dsRNA, TLR3 signals through a molecular pathway that 
requires adaptor protein TRIF to activate transcription factors, 
IRF3 and NF-κB, triggering the production of type I interferon 
(IFN-1) and inflammatory cytokines, such as IL-8 and IL-6 (33). 
The EGF, ErbB1 and Btk, can phosphorylate two tyrosine residues 
in the cytoplasmic domain of TLR3 in order to facilitate interac-
tion with TRIF (34, 35).
Despite most commonly being reported to reside in the 
intracellular endosomes, TLR3 has also been observed on the cell 
surface in some endothelial, epithelial, and fibroblastic cells in the 
presence of dsRNA and UNC93B1 (an accessory TLR protein) 
(36–38). The TLR3 ectodomain is required for its translocation to 
the plasma membrane (39). Recently, it was shown that TLR3 can 
interact with SREC-I in the presence of TLR3 ligand. Upon PIC 
(poly I:C, dsRNA) treatment, TLR3 and SREC-I can colocalize 
to the endosomes in THP-1 monocytes (40). The formation of 
the SREC-I–TLR3–PIC complex led to higher rates of NF-κB 
pathway activity and greater expression of phosphorylated 
(activated) MAP kinases p38 and c-jun kinase (JNK), along with 
secretion of pro-inflammatory cytokines, such as IL-8 and IL-6 
(40) (Figure 1). Thus, TLR3 occupies SREC-I as a coreceptor and 
enhances its PIC-mediated activation (40).
SReC-i iN iMMUNiTY AND DiSeASe: 
wHAT ReMAiNS UNKNOwN AND 
FUTURe DiReCTiONS
SREC-I has been characterized as a receptor for extracellular 
HSPs, gp96, and modified LDL. This promiscuous receptor is a 
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key component of innate immunity and is capable of recogniz-
ing TLR ligands, such as LPS, unmethylated DNA, or dsRNA. 
However, it has recently been shown to participate both in innate 
and adaptive immunity in endothelial cells, fibroblasts, and 
immune cells. In addition to internalizing HSPs, Means’ group 
demonstrated that SREC-I can endocytose apoptotic cells by 
recognizing phosphatidylserine exposed on the outer leaflet of 
the plasma membrane and with the help of complement factor 
C1q (41). They also strongly reported that failure of this removal 
in  vivo resulted in spontaneous development of autoimmune 
disease (41). It would be interesting to find out more how 
SREC-I can protect against autoimmunity and to understand 
the molecular basis for this property of SREC-I. Such work may 
ultimately enable modulation of SREC-I activity in contexts of 
autoimmunity for therapeutic benefit. Indeed, it has been shown 
that defective clearance of apoptotic cells by the scavenger recep-
tors increases susceptibility to lupus (41). In addition to contexts 
of autoimmunity, understanding SREC-I function in apoptotic 
cell uptake and identifying its interacting partners will also open 
up the field to understanding infection-driven immune responses 
regulated by SREC-I. For its functional versatility and versatility 
in ligand, recognition makes it the scavenging Jack of all Trades.
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